Breast oncology Clinical Trials in Duarte, CA
As of August 2026, 39 paid clinical trials are recruiting for Breast oncology in Duarte, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Duarte
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
40 clinical trials for Breast oncology
·Clear filters·A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
Top Research Study Locations in Duarte
Researchers run research studies in Duarte, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| City of Hope Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Myelodysplastic Syndrome | 178 |
| City of Hope | Breast Cancer, Gastric Cancer, Cervical Cancer | 133 |
| City of Hope Comprehensive Cancer Center | Metastatic Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Hematopoietic and Lymphatic System Neoplasm | 84 |
| City of Hope National Medical Center | Breast Cancer, Solid Tumor, Advanced Solid Tumor | 53 |
| City of Hope (City of Hope National Medical Center, City of Hope Medical Center) | Pancreatic Ductal Adenocarcinoma, Acute Myeloid Leukemia, Advanced Breast Cancer | 9 |
| City of Hope Cancer Center | Advanced Solid Tumors, Breast Cancer, Cervical Cancer | 6 |
| City of Hope - Duarte Cancer Center | Advanced Metastatic Castration-resistant Prostate Cancer, Advanced Solid Tumors, Advanced/Metastatic Colorectal Adenocarcinoma | 5 |
| City of Hope - Duarte | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Anemia, KRAS G12C-mutated Solid Tumors, Lung Cancer | 4 |
| City of Hope Duarte | Multiple Myeloma, Advanced Colorectal Cancer, CRC | 3 |
| City of Hope Cancer Center (Data collection only) | Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 3 |
| Beckman Research Institute of City of Hope | Cancer, End of Life, Prostate Cancer | 2 |
| City of Hope Investigational Drug Services (IDS) | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 2 |
| City of Hope National Cancer Center | Esophageal Cancer, Gastric Cancer (GC), Gastroesophageal Junction | 2 |
| Dren Investigational Site | Aggressive NK Cell Leukemia, Aplastic Anemias, Bone Marrow Failure Syndromes | 2 |
| IP Address: City of Hope Investigational Drug Services(IDS) | Acute Myeloid Leukemia, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms | 2 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Beckman Research Institute of the City of Hope | Prostate Adenocarcinoma | 1 |
| City Of Hope Comprehensive Cancer Center | Advanced Squamous Tumors | 1 |
| City of Hope - Comprehensive Cancer Center (CCC) | Anemia, Myelodysplastic Syndrome | 1 |
| City of Hope - Duarte Main Site | Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis | 1 |
| City of Hope - National Medical Center | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 1 |
| City of Hope -Duarte Cancer Center | Ductal Carcinoma in Situ | 1 |
| City of Hope Blood Donor Center | Anemia, Anemia, Iron Deficiency, IDA - Iron Deficiency Anemia | 1 |
| City of Hope Cancer Center (Data Analysis Only) | Cancer, Recurrence, Recurrent | 1 |
| City of Hope Cancer Center (Data collection AND Specimen Analysis) | Acute Lymphoblastic Leukemia | 1 |
Active & Upcoming Studies in Duarte (2026)
Recruiting trials in Duarte grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (406 active studies)
- Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial · Phase 2 · City of Hope Medical Center
- Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma · Phase 1 · City of Hope Medical Center
Diabetes & metabolic (6 active studies)
- Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes · EARLY_Phase 1 · City of Hope Medical Center
- A Study of GNTI-122 in Adults Recently Diagnosed With T1D · Phase 1 · GentiBio, Inc
Vaccines (3 active studies)
- Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals · Phase 2 · Fred Hutchinson Cancer Center
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study · Phase 3 · Ansun Biopharma, Inc.
HIV / STI (2 active studies)
- Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · Phase 1 · AIDS Malignancy Consortium
- CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS · EARLY_Phase 1 · City of Hope Medical Center
Neurology & pain (1 active study)
- Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma · University of Southern California
Cardiovascular (1 active study)
Common conditions studied in Duarte
- Acute Myeloid Leukemia (23 active studies)
- Breast Cancer (15 active studies)
- Multiple Myeloma (15 active studies)
- Myelodysplastic Syndrome (14 active studies)
- Ovarian Cancer (14 active studies)
- Malignant Solid Neoplasm (13 active studies)
Leading research sponsors in Duarte
- City of Hope Medical Center
- National Cancer Institute (NCI)
- AstraZeneca
- AbbVie
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Duarte?
There are approximately 548 recruiting clinical trials in Duarte, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Duarte pay participants?
Most recruiting trials in Duarte compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Duarte?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Duarte?
The most common conditions under active study in Duarte include Acute Myeloid Leukemia (23), Breast Cancer (15), Multiple Myeloma (15), Myelodysplastic Syndrome (14), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Duarte?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Duarte on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Duarte?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Duarte?
Recruiting research sites in Duarte include City of Hope Medical Center, City of Hope, City of Hope Comprehensive Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Duarte right now?
The largest active categories in Duarte are Cancer & tumors (406), Diabetes & metabolic (6), Vaccines (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.